Growth Metrics

Quest Diagnostics (DGX) Total Non-Current Liabilities: 2009-2025

Historic Total Non-Current Liabilities for Quest Diagnostics (DGX) over the last 17 years, with Sep 2025 value amounting to $7.9 billion.

  • Quest Diagnostics' Total Non-Current Liabilities fell 5.30% to $7.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $7.9 billion, marking a year-over-year decrease of 5.30%. This contributed to the annual value of $8.4 billion for FY2024, which is 23.49% up from last year.
  • As of Q3 2025, Quest Diagnostics' Total Non-Current Liabilities stood at $7.9 billion, which was up 1.36% from $7.8 billion recorded in Q2 2025.
  • In the past 5 years, Quest Diagnostics' Total Non-Current Liabilities ranged from a high of $8.4 billion in Q4 2024 and a low of $5.9 billion during Q1 2023.
  • In the last 3 years, Quest Diagnostics' Total Non-Current Liabilities had a median value of $6.8 billion in 2023 and averaged $7.1 billion.
  • In the last 5 years, Quest Diagnostics' Total Non-Current Liabilities declined by 8.33% in 2021 and then surged by 36.09% in 2024.
  • Quest Diagnostics' Total Non-Current Liabilities (Quarterly) stood at $6.3 billion in 2021, then decreased by 3.80% to $6.1 billion in 2022, then grew by 11.63% to $6.8 billion in 2023, then increased by 23.49% to $8.4 billion in 2024, then declined by 5.30% to $7.9 billion in 2025.
  • Its Total Non-Current Liabilities was $7.9 billion in Q3 2025, compared to $7.8 billion in Q2 2025 and $7.9 billion in Q1 2025.